Technical Articles

KRAS G13D & CRBN Binding Kit (GTP load)
KRAS G13D突变结直肠癌对西妥昔单抗敏感性的分子机制
Molecular mechanism of KRAS G13D mutation colorectal cancer sensitivity to cetuximab
发布时间 2026-03-03
Colorectal cancer is one of the most prevalent malignant tumors in China. With the advancement of precision medicine, its treatment strategies increasingly rely on in-depth analysis of the tumor's molecular characteristics.
View details
  • Cancer
  • KRAS G13D & CRBN Binding Kit (GTP load)
  • Colorectal cancer
  • Malignant tumor
Total 1
  • 1
Go to
UA
Link：
Products
Application
Cell FactorTarget Proteins
Custom Services
Custom Protein Expression ServicesCustom SPR Services
About Us
PromotionTechnical ArticlesProduct ApplicationFAQsCitationsAbout Us
We Media：
Facebook Linkedin YouTube X Thraeds Pinterest
©2021-2026 all rights reserved UA Biotechnology Co.,Ltd.
Privacy Policy
网站备案号 浙ICP备2022019033号-2 浙公网安备33010202004867号
 Business license (three certificates in one)
Tel：+86-25-56221161
E-mail：order@ua-bio.com
All products sold on this website shall not be used for clinical diagnosis or treatment of humans or animals, and shall only be used for non-medical purposes such as industrial or scientific research.